These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 4263510)

  • 1. Specificity of destruction by lymphocytes activated in mixed leukocyte culture.
    Lightbody JJ; Bach FH
    Transplant Proc; 1972 Sep; 4(3):307-10. PubMed ID: 4263510
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell-mediated lympholysis in vitro with normal lymphocytes as target: specificity and cross-reactivity of the test.
    Miggiano VC; Bernoco D; Lightbody J; Trinchieri G; Ceppellini R
    Transplant Proc; 1972 Jun; 4(2):231-7. PubMed ID: 5034149
    [No Abstract]   [Full Text] [Related]  

  • 3. Lymphocyte activation and destruction in vitro in relation to MLC and HL-A.
    Eijsvoogel VP; Du Bois R; Melief CJ; Zeylemaker WP; Raat-Koning L; de Groot-Kooy L
    Transplant Proc; 1973 Mar; 5(1):415-20. PubMed ID: 4121172
    [No Abstract]   [Full Text] [Related]  

  • 4. The cellular immunity of mother versus child at delivery: sensitization in unidirectional mixed lymphocyte culture and subsequent 51-Cr-release cytotoxicity test.
    Bonnard GD; Lemos L
    Transplant Proc; 1972 Jun; 4(2):177-80. PubMed ID: 5034146
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro correlates of cell-mediated immunity in the human.
    Bach JF
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:161-73. PubMed ID: 4277530
    [No Abstract]   [Full Text] [Related]  

  • 6. Autologous plasma affecting the maternal response in mixed lymphocyte cultures with the newborn.
    Imre G; Petri I; Keserü TL; Obál M
    Haematologia (Budap); 1973; 7(2):193-8. PubMed ID: 4275101
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of water-soluble adjuvants on in vitro lymphocyte immunization.
    Sharma B; Koashi O; Mickey MR; Terasaki P
    Cancer Res; 1975 Mar; 35(3):666-9. PubMed ID: 123169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte reactivity in vitro. VI. Specificity of target cell destruction following in vitro sensitization in mixed leukocyte cultures.
    Solliday S; Bach FH
    Eur J Immunol; 1972 Feb; 2(1):68-72. PubMed ID: 4263648
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of irradiated and mitomycin-treated mouse spleen cells as stimulating cells in mixed lymphocyte cultures and in vitro sensitization.
    Hodes RJ; Terry WD
    J Immunol; 1974 Jul; 113(1):39-44. PubMed ID: 4275549
    [No Abstract]   [Full Text] [Related]  

  • 10. The response of alloimmune human lymphocytes in mixed lymphocyte culture tests.
    Bondevik H; Thorsby E
    Transplant Proc; 1973 Dec; 5(4):1477-80. PubMed ID: 4272813
    [No Abstract]   [Full Text] [Related]  

  • 11. Formation of cytotoxic lymphocytes in mixed leukocyte culture systems: introduction.
    Cerottini JC; MacDonald HR; Brunner KT
    Transplant Proc; 1973 Dec; 5(4):1621-4. PubMed ID: 4130070
    [No Abstract]   [Full Text] [Related]  

  • 12. Enhancing antibody: in vitro studies on mechanism of action upon the sensitization and effector arc.
    Phillips SM; Strom TB; Corson JM; Carpenter CB; Merrill JP
    Transplant Proc; 1973 Mar; 5(1):577-80. PubMed ID: 4266670
    [No Abstract]   [Full Text] [Related]  

  • 13. 51 Chromium-release assay for cell-mediated cytotoxicity of human leukemia and lymphoid tissue-culture cells.
    McCoy JL; Herberman RB; Rosenberg EB; Donnelly FC; Levine PH; Alford C
    Natl Cancer Inst Monogr; 1973 Jun; 37():59-67. PubMed ID: 4123455
    [No Abstract]   [Full Text] [Related]  

  • 14. Impaired responsiveness of lymphocytes and serum-inhibitory factors in patients with cancer.
    Suciu-Foca N; Buda J; McManus J; Thiem T; Reemtsma K
    Cancer Res; 1973 Oct; 33(10):2373-7. PubMed ID: 4270240
    [No Abstract]   [Full Text] [Related]  

  • 15. Lymphocyte-mediated cytotoxicity against human allogeneic and autologous lymphoid targets after concanavalin A-activation of cytotoxic effector cells.
    Hunninghake GW; Fauci AS
    J Immunol; 1977 Sep; 119(3):1122-8. PubMed ID: 70470
    [No Abstract]   [Full Text] [Related]  

  • 16. Impaired in vitro cell-mediated immunity to rubella virus during pregnancy.
    Thong YH; Steele RW; Vincent MM; Hensen SA; Bellanti JA
    N Engl J Med; 1973 Sep; 289(12):604-6. PubMed ID: 4269242
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro immunization to cultured human tumor cells.
    Sharma B; Terasaki PI
    Cancer Res; 1974 Jan; 34(1):115-8. PubMed ID: 4129196
    [No Abstract]   [Full Text] [Related]  

  • 18. Cell mediated lympholysis in man after sensitization of effector lymphocytes through mixed leukocyte cultures.
    Lightbody J; Bernoco D; Miggiano VC; Ceppellini R
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1971; 64(9):243-54. PubMed ID: 5155939
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell-mediated immune reactions in vitro: cytotoxicity of lymphocytes activated by phytohemagglutinin and anti-immunoglobulin serum.
    Resch K; Fischer H
    Eur J Immunol; 1971 Aug; 1(4):271-5. PubMed ID: 5316633
    [No Abstract]   [Full Text] [Related]  

  • 20. Cell mediated lympholysis: effect of papain on effector and target cells.
    Lightbody JJ; Bach FH
    Ann Immunol (Paris); 1973 Aug; 124(3):311-9. PubMed ID: 4272624
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.